Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/679441


South Africa Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012


Description: South Africa Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to South Africa neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the neurology devices in South Africa

Scope

- The report provides neurology devices information broken down into detailed categories and segments in South Africa.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the neurology devices market in South Africa.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Contents: 1 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What Is This Report About? 11
3 Definitions of Markets Covered in the Report 12
3.1 Neurology Devices 12
3.2 CSF (Cerebro Spinal Fluid) Management 12
3.2.1 Hydrocephalus shunt 12
3.2.2 Intra Cranial Pressure (ICP) Monitors 12
3.3 Interventional Neurology 12
3.3.1 Aneurysm Clips 12
3.3.2 Embolic System 12
3.3.3 Navigational System 13
3.4 Neurostimulation Device 13
3.4.1 Spinal Cord Stimulator (SCS) 13
3.4.2 Deep Brain Stimulator (DBS) 13
3.4.3 Vagus Nerve stimulation (VNS) 13
3.5 Neurosurgical Products (Neuroendoscopes) 14
3.5.1 Neurosurgical Products (Neuroendoscopes) 14
3.6 Radio surgery 14
3.6.1 Cyber Knife Radiosurgery 14
3.6.2 Gamma Knife Radiosurgery 14
4 Healthcare Sector Review 15
5 Regulation System 16
5.1 Medical Equipment Regulation System 16
5.2 Regulation of Electromagnetic Medical Devices 16
5.3 Future Outlook 19
6 Pricing and Reimbursement 20
6.1 Reimbursement 20
6.2 Pricing 20
7 Distribution Structure 21
8 Neurology Devices In South Africa 22
8.1 Neurology Devices Cross Country Comparison (2000-2012) 22
8.2 Neurology Devices, South Africa, Overall Revenues ($ mn), 2000-2012 23
8.3 Neurology Devices, South Africa, Category Volume (Units), 2000-2012 27
8.4 Neurology Devices, South Africa, Company Share (2006-2007) 29
9 CSF Management In South Africa 30
9.1 CSF Management Overall Revenue (2000-2012) 30
9.2 CSF Management Overall Volume (2000-2012) 32
9.3 CSF Management Average Price (2000-2012) 34
9.4 CSF Management Distribution Share (2006-2007) 35
9.5 CSF Management, South Africa, Company Share (2006-2007) 36
10 Interventional Neurology In South Africa 37
10.1 Interventional Neurology Overall Revenue (2000-2012) 37
10.1.1 Embolic Systems Overall Revenues (2000-2012) 39
10.1.2 Navigational Systems Overall Revenues (2000-2012) 41
10.2 Interventional Neurology Overall Volume (2000-2012) 43
10.2.1 Embolic Systems Overall Volume (2000-2012) 45
10.2.2 Navigational Systems Overall Volume (2000-2012) 47
10.3 Interventional Neurology Average Price (2000-2012) 49
10.4 Interventional Neurology Distribution Share (2006-2007) 50
10.5 Interventional Neurology, South Africa, Company Share (2006-2007) 51
11 Neurostimulation Devices In South Africa 52
11.1 Neurostimulation Devices Overall Revenue (2000-2012) 52
11.2 Neurostimulation Devices Overall Volume (2000-2012) 54
11.3 Neurostimulation Devices Average Price (2000-2012) 56
11.4 Neurostimulation Devices Distribution Share (2006-2007) 57
11.5 Neurostimulation Devices, South Africa, Company Share (2006-2007) 58
12 Neurosurgical Products (Neuroendoscopes) In South Africa 59
12.1 Neurosurgical Products (Neuroendoscopes) Overall Revenue (2000-2012) 59
12.2 Neurosurgical Products (Neuroendoscopes) Overall Volume (2000-2012) 61
12.3 Neurosurgical Products (Neuroendoscopes) Average Price (2000-2012) 63
12.4 Neurosurgical Products (Neuroendoscopes) Distribution Share (2006-2007) 64
12.5 Neurosurgical Products (Neuroendoscopes), South Africa, Company Share (2006-2007) 65
13 Medtronic, Inc. Company Profile 66
13.1 Company Overview 66
13.2 Value Chain Analysis 66
13.2.1 Manufacturing 67
13.2.2 Product Development 67
13.2.3 Sales and Marketing 67
13.3 Medtronic, Inc. Pipeline Products 68
13.3.1 Medtronic, Inc. Pipeline Products by Equipment Type 68
13.3.2 Medtronic, Inc. Pipeline Products by Development Stage 70
13.3.3 Medtronic, Inc. Pipeline Products by Therapy Area 72
13.3.4 Medtronic, Inc. Pipeline Products by Clinical Trials 74
13.3.5 Medtronic, Inc. Pipeline Products by News Summary 75
14 Codman & Shurtleff, Inc. Company Profile 76
14.1 Company Overview 76
15 B. Braun Melsungen AG Company Profile 77
15.1 Company Overview 77
15.2 Value Chain Analysis 77
15.2.1 Manufacturing 78
15.2.2 Product Development 78
15.2.3 Sales and Marketing 79
15.2.4 B. Braun Melsungen AG Pipeline Products by Equipment Type 80
15.2.5 B. Braun Melsungen AG Pipeline Products by Development Stage 80
15.2.6 B. Braun Melsungen AG Pipeline Products by Therapy Area 80
15.2.7 B. Braun Melsungen AG Pipeline Products by Clinical Trials 81
15.2.8 B. Braun Melsungen AG Pipeline Products by News Summary 81
16 Cyberonics, Inc. Company Profile 82
16.1 Company Overview 82
16.1.1 Cyberonics, Inc. Pipeline Products by Equipment Type 83
16.1.2 Cyberonics, Inc. Pipeline Products by Development Stage 83
16.1.3 Cyberonics, Inc. Pipeline Products by Therapy Area 83
17 Boston Scientific Corporation Company Profile 84
17.1 Company Overview 84
17.2 Value Chain Analysis 84
17.2.1 Manufacturing 85
17.2.2 Product Development 85
17.2.3 Sales and Marketing 86
17.3 Boston Scientific Corporation Pipeline Products 87
17.3.1 Boston Scientific Corporation Pipeline Products by Equipment Type 87
17.3.2 Boston Scientific Corporation Pipeline Products by Development Stage 88
17.3.3 Boston Scientific Corporation Pipeline Products by Therapy Area 89
17.3.4 Boston Scientific Corporation Pipeline Products by Clinical Trials 90
17.3.5 Boston Scientific Corporation Pipeline Products by News Summary 91
18 Appendix 93
18.1 Global Markets Direct Research Methodology 93
18.2 Coverage 94
18.3 Secondary Research 94
18.4 Primary Research 95
18.5 Models 95
18.6 Forecasts 96
18.7 Expert Panels 96
18.8 Currency Conversion 97
18.9 Contact Us 98
18.10 Disclaimer 98

Executive Summary

1.2 List of Figures
Figure 1: Neurology Devices Cross Country Comparison (2000-2012) 22
Figure 2: Neurology Devices, South Africa, Overall Revenues ($ mn), 2000-2012 23
Figure 3: Neurology Devices, South Africa, Portfolio Analysis, 2000-2012 24
Figure 4: Neurology Devices, South Africa, Overall Revenues ($ mn), Historic, 2000-2007 25
Figure 5: Neurology Devices, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012 26
Figure 6: Neurology Devices, South Africa, Company Share (%), 2007 29
Figure 7: CSF Management, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2007 30
Figure 8: CSF Management, South Africa, Revenue ($ mn) by Segment, Forecast, 2007-2012 31
Figure 9: CSF Management, South Africa, Overall Volume (Units), Historic, 2000-2007 32
Figure 10: CSF Management, South Africa, Overall Volume (Units), Forecast, 2007-2012 33
Figure 11: CSF Management, South Africa, Company Share (%), 2007 36
Figure 12: Interventional Neurology, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2007 37
Figure 13: Interventional Neurology, South Africa, Revenue ($ mn) by Segment, Forecast, 2007-2012 38
Figure 14: Embolic Systems, South Africa, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 39
Figure 15: Embolic Systems, South Africa, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 40
Figure 16: Navigational Systems, South Africa, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 41
Figure 17: Navigational Systems, South Africa, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 42
Figure 18: Interventional Neurology, South Africa, Overall Volume (Units), Historic, 2000-2007 43
Figure 19: Interventional Neurology, South Africa, Overall Volume (Units), Forecast, 2007-2012 44
Figure 20: Embolic Systems, South Africa, Volume (Units) by Sub-Segment, Historic, 2000-2007 45
Figure 21: Embolic Systems, South Africa, Volume (Units) by Sub-Segment, Forecast, 2007-2012 46
Figure 22: Navigational Systems, South Africa, Volume (Units) by Sub-Segment, Historic, 2000-2007 47
Figure 23: Navigational Systems, South Africa, Volume (Units) by Sub-Segment, Forecast, 2007-2012 48
Figure 24: Interventional Neurology, South Africa, Company Share (%), 2007 51
Figure 25: Neurostimulation Devices, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2007 52
Figure 26: Neurostimulation Devices, South Africa, Revenue ($ mn) by Segment, Forecast, 2007-2012 53
Figure 27: Neurostimulation Devices, South Africa, Overall Volume (Units), Historic, 2000-2007 54
Figure 28: Neurostimulation Devices, South Africa, Overall Volume (Units), Forecast, 2007-2012 55
Figure 29: Neurostimulation Devices, South Africa, Company Share (%), 2007 58
Figure 30: Neurosurgical Products (Neuroendoscopes), South Africa, Revenue ($ mn), Historic, 2000-2007 59
Figure 31: Neurosurgical Products (Neuroendoscopes), South Africa, Revenue ($ mn) by Segment, Forecast, 2007-2012 60
Figure 32: Neurosurgical Products (Neuroendoscopes), South Africa, Overall Volume (Units), Historic, 2000-2007 61
Figure 33: Neurosurgical Products (Neuroendoscopes), South Africa, Overall Volume (Units), Forecast, 2007-2012 62
Figure 34: Neurosurgical Products (Neuroendoscopes), South Africa, Company Share (%), 2007 65
Figure 35: Medtronic, Inc. Value Chain Analysis 66
Figure 36: B. Braun Melsungen AG Value Chain Analysis 77
Figure 37: Boston Scientific Corporation Value Chain Analysis 84
Figure 38: Global Markets Direct Methodology 93


Companies Mentioned Medtronic, Inc. Codman & Shurtleff, Inc. B. Braun Melsungen AG Cyberonics, Inc. Boston Scientific Corporation


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/679441

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 27/11/2009 06:41:45
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
South Africa Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Web Address:
http://www.researchandmarkets.com/reports/679441
Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €2,015.00
Electronic (PDF) - Site License €4,030.00
Electronic (PDF) - Enterprisewide €6,044.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 27/11/2009 06:41:45

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)